# Non-Invasive Risk Stratification for Hepatocellular Carcinoma in HCV-Related Compensated Advanced Chronic Liver Disease Following Sustained Virological Response: Validation of the aMAP Score

> **NCT07687758** · — · COMPLETED · sponsor: **Siriraj Hospital** · enrollment: 571 (actual)

## Conditions studied

- Hepatitis C Virus Infection
- Compensated Advanced Chronic Liver Disease
- Hepatocellular Carcinoma (HCC)

## Interventions

- **OTHER:** Non-invasive Risk Score Assessment

## Key facts

- **NCT ID:** NCT07687758
- **Lead sponsor:** Siriraj Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01-01
- **Primary completion:** 2023-07-31
- **Final completion:** 2023-07-31
- **Target enrollment:** 571 (ACTUAL)
- **Last updated:** 2026-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07687758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07687758, "Non-Invasive Risk Stratification for Hepatocellular Carcinoma in HCV-Related Compensated Advanced Chronic Liver Disease Following Sustained Virological Response: Validation of the aMAP Score". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07687758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*